deltatrials
Unknown NCT02161315

Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast Cancer

A Randomized Study of Steroid Aromatase Inhibitors Versus Progestogens for Non-Steroid Aromatase Inhibitor-resistanced Late Stage Breast Cancer

Sponsor: Tianjin Medical University Cancer Institute and Hospital

Conditions Carcinoma Breast Stage IV
Updated 6 times since 2017 Last updated: Dec 21, 2015 Started: Apr 30, 2014 Primary completion: Nov 30, 2016 Completion: Dec 31, 2016

A observational or N/A phase clinical study on Carcinoma Breast Stage IV, this trial is ongoing. The trial is conducted by Tianjin Medical University Cancer Institute and Hospital and has accumulated 6 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status

  5. Apr 2018 — Jun 2018 [monthly]

    Unknown Status

    Phase: NA → None

▶ Show 1 earlier version

  1. Jan 2017 — Apr 2018 [monthly]

    Unknown Status NA

    First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Tianjin Medical University Cancer Institute and Hospital
Data source: Tianjin Medical University Cancer Institute and Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Tianjin, China